Beihai Gofar Marine Biological Industry Co Ltd (600538) - Net Assets
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has net assets worth CN¥690.53 Million CNY (≈ $101.05 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥878.46 Million ≈ $128.55 Million USD) and total liabilities (CN¥187.93 Million ≈ $27.50 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Beihai Gofar Marine Biological Industry (600538) strategic asset index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥690.53 Million |
| % of Total Assets | 78.61% |
| Annual Growth Rate | 7.81% |
| 5-Year Change | -24.04% |
| 10-Year Change | 1.74% |
| Growth Volatility | 115.34 |
Beihai Gofar Marine Biological Industry Co Ltd - Net Assets Trend (1999–2025)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 600538 stock market capitalisation.
Annual Net Assets for Beihai Gofar Marine Biological Industry Co Ltd (1999–2025)
The table below shows the annual net assets of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2025. Also explore net asset momentum of Beihai Gofar Marine Biological Industry to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥700.78 Million ≈ $102.55 Million |
-11.00% |
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
-10.45% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
-8.40% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
+4.05% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
+8.34% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
+31.90% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
+1.26% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
-3.28% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
-4.30% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
-6.65% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
+1.13% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
+554.16% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
+21.76% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
-52.20% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
-15.02% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
+8.73% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
-36.28% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
-33.98% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
-6.89% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
-3.98% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
+5.59% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
+9.04% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
+224.58% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
+13.36% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
+23.39% |
| 2000-12-31 | CN¥105.48 Million ≈ $15.44 Million |
+6.42% |
| 1999-12-31 | CN¥99.12 Million ≈ $14.50 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Beihai Gofar Marine Biological Industry Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3006.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥1.34 Billion | 195.12% |
| Total Equity | CN¥687.78 Million | 100.00% |
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Market Cap
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
$376.03 Million |
|
Dongwoon Anatech Co Ltd
KQ:094170
|
$376.04 Million |
|
BP p.l.c
LSE:BP-B
|
$376.09 Million |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
$376.16 Million |
|
Shenzhen Prolto Supply Chain Management Co Ltd
SHE:002769
|
$375.84 Million |
|
Kap Industrial Holdings Ltd
JSE:KAP
|
$375.82 Million |
|
Aydem Yenilenebilir Enerji AS
IS:AYDEM
|
$375.81 Million |
|
Beijing Capital International Airport Company Limited
F:BJ1
|
$375.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beihai Gofar Marine Biological Industry Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 775,386,925 to 687,776,512, a change of -87,610,413 (-11.3%).
- Net loss of 87,621,043 reduced equity.
- Dividend payments of 177,911 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-87.62 Million | -12.74% |
| Dividends Paid | CN¥177.91K | -0.03% |
| Other Changes | CN¥188.54K | +0.03% |
| Total Change | CN¥- | -11.30% |
Book Value vs Market Value Analysis
This analysis compares Beihai Gofar Marine Biological Industry Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.73x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13.44x to 3.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | CN¥0.36 | CN¥4.90 | x |
| 2000-12-31 | CN¥0.39 | CN¥4.90 | x |
| 2001-12-31 | CN¥0.48 | CN¥4.90 | x |
| 2002-12-31 | CN¥0.71 | CN¥4.90 | x |
| 2003-12-31 | CN¥2.29 | CN¥4.90 | x |
| 2004-12-31 | CN¥2.41 | CN¥4.90 | x |
| 2005-12-31 | CN¥2.50 | CN¥4.90 | x |
| 2006-12-31 | CN¥1.73 | CN¥4.90 | x |
| 2007-12-31 | CN¥1.84 | CN¥4.90 | x |
| 2008-12-31 | CN¥1.10 | CN¥4.90 | x |
| 2009-12-31 | CN¥0.58 | CN¥4.90 | x |
| 2010-12-31 | CN¥0.65 | CN¥4.90 | x |
| 2011-12-31 | CN¥0.49 | CN¥4.90 | x |
| 2012-12-31 | CN¥0.10 | CN¥4.90 | x |
| 2013-12-31 | CN¥0.17 | CN¥4.90 | x |
| 2014-12-31 | CN¥1.79 | CN¥4.90 | x |
| 2015-12-31 | CN¥1.68 | CN¥4.90 | x |
| 2016-12-31 | CN¥1.43 | CN¥4.90 | x |
| 2017-12-31 | CN¥1.49 | CN¥4.90 | x |
| 2018-12-31 | CN¥1.48 | CN¥4.90 | x |
| 2019-12-31 | CN¥1.34 | CN¥4.90 | x |
| 2020-12-31 | CN¥1.85 | CN¥4.90 | x |
| 2021-12-31 | CN¥1.75 | CN¥4.90 | x |
| 2022-12-31 | CN¥1.91 | CN¥4.90 | x |
| 2023-12-31 | CN¥1.69 | CN¥4.90 | x |
| 2024-12-31 | CN¥1.49 | CN¥4.90 | x |
| 2025-12-31 | CN¥1.31 | CN¥4.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beihai Gofar Marine Biological Industry Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.69%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.30x
- Recent ROE (-12.74%) is above the historical average (-18.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 16.37% | 25.27% | 0.38x | 1.68x | CN¥6.31 Million |
| 2000 | 14.89% | 19.16% | 0.42x | 1.87x | CN¥5.13 Million |
| 2001 | 19.00% | 26.15% | 0.46x | 1.60x | CN¥11.65 Million |
| 2002 | 16.68% | 23.93% | 0.42x | 1.66x | CN¥9.49 Million |
| 2003 | 6.15% | 12.15% | 0.31x | 1.62x | CN¥-17.62 Million |
| 2004 | 3.37% | 4.34% | 0.36x | 2.17x | CN¥-31.87 Million |
| 2005 | 3.56% | 3.84% | 0.36x | 2.54x | CN¥-32.11 Million |
| 2006 | -6.43% | -5.60% | 0.41x | 2.77x | CN¥-77.22 Million |
| 2007 | 0.64% | 0.38% | 0.60x | 2.75x | CN¥-44.51 Million |
| 2008 | -57.65% | -54.21% | 0.27x | 3.94x | CN¥-207.36 Million |
| 2009 | -86.63% | -57.36% | 0.26x | 5.90x | CN¥-154.41 Million |
| 2010 | 9.28% | 4.52% | 0.51x | 4.00x | CN¥-1.27 Million |
| 2011 | -28.35% | -7.38% | 0.76x | 5.06x | CN¥-52.81 Million |
| 2012 | -389.29% | -20.18% | 0.88x | 21.81x | CN¥-112.38 Million |
| 2013 | 24.03% | 2.36% | 0.65x | 15.53x | CN¥6.24 Million |
| 2014 | -7.25% | -11.84% | 0.42x | 1.46x | CN¥-117.01 Million |
| 2015 | 0.59% | 0.80% | 0.51x | 1.44x | CN¥-64.17 Million |
| 2016 | -4.90% | -12.10% | 0.27x | 1.47x | CN¥-96.89 Million |
| 2017 | 1.34% | 3.81% | 0.30x | 1.18x | CN¥-57.07 Million |
| 2018 | -3.39% | -9.63% | 0.29x | 1.20x | CN¥-85.37 Million |
| 2019 | 0.89% | 2.30% | 0.33x | 1.16x | CN¥-58.79 Million |
| 2020 | 0.38% | 1.20% | 0.25x | 1.26x | CN¥-81.24 Million |
| 2021 | 1.14% | 2.47% | 0.39x | 1.18x | CN¥-81.18 Million |
| 2022 | 3.66% | 7.58% | 0.40x | 1.20x | CN¥-60.31 Million |
| 2023 | -9.47% | -22.30% | 0.35x | 1.21x | CN¥-169.23 Million |
| 2024 | -12.10% | -27.57% | 0.35x | 1.25x | CN¥-171.39 Million |
| 2025 | -12.74% | -26.69% | 0.37x | 1.30x | CN¥-156.40 Million |
Industry Comparison
This section compares Beihai Gofar Marine Biological Industry Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $5,065,162,570
- Average return on equity (ROE) among peers: -54.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beihai Gofar Marine Biological Industry Co Ltd (600538) | CN¥690.53 Million | 16.37% | 0.27x | $375.86 Million |
| Hubei Yihua Chemical Industry Co Ltd (000422) | $290.93 Million | 18.67% | 0.30x | $1.94 Billion |
| Nanjing Red Sun Co Ltd (000525) | $591.59 Million | -632.89% | 15.41x | $887.03 Million |
| ADAMA Ltd (000553) | $21.43 Billion | 1.65% | 1.18x | $1.79 Billion |
| Grand Industrial Holding Co Ltd (000626) | $2.01 Billion | 15.34% | 3.29x | $684.27 Million |
| Sichuan Meifeng Chemical Industry Co Ltd (000731) | $628.24 Million | 9.39% | 0.26x | $664.97 Million |
| Qinghai Salt Lake Industry Co.Ltd (000792) | $11.65 Billion | 38.44% | 1.17x | $19.26 Billion |
| Asia Potash International Investment Guangzhou Co Ltd (000893) | $3.89 Billion | -17.67% | 0.09x | $5.37 Billion |
| Hubei Xinyangfeng Fertilizer Co Ltd (000902) | $8.22 Billion | 14.71% | 0.60x | $2.53 Billion |
| Sichuan Lutianhua Co Ltd (000912) | $2.03 Billion | 5.63% | 0.81x | $968.27 Million |
| Guangxi Hechi Chemical Co Ltd (000953) | $-89.10 Million | 0.00% | 0.00x | $330.56 Million |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, phar… Read more